|
Virtual Interviewing: Finding the Right Fellowship Fit Remotely |
|
Enduring |
|
$0.00 |
|
Session 2: Root Causes of Health Disparities |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
|
Keeping Up With the Chemos: CDK4/6 Inhibitors - Follow Up (Part 3) |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Current Treatment Decisions for Front Line Ovarian Cancer |
|
Enduring |
|
$0.00 |
|
Scientific Plenary IV: Late-breaking Abstracts |
|
Enduring |
|
$0.00 |
|
Focused Plenary III: Biomarkers: Prediction and Prognosis |
|
Enduring |
|
$0.00 |
|
SGO Oncofertility Part 2: Risks of Premature Ovarian Failure |
|
Enduring |
|
$0.00 |
|
Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2): Full Seminar |
|
Enduring |
|
$0.00 |
|
Immunotherapy Part 1: Basics of Immune-Related Adverse Events |
|
Enduring |
|
$0.00 |
|
Pain Management in Gynecologic Oncology and the Opioid Crisis |
|
Enduring |
|
$0.00 |
|
Key Concepts of Enhanced Recovery After Surgery: ERAS–Why Do We Do It? |
|
Enduring |
|
$0.00 |
|
Brain Metastasis Considerations in Gynecologic Oncology Patients |
|
Enduring |
|
$0.00 |
|
NCI Grants for Training & Career Development |
|
Enduring |
|
$0.00 |
|
Navigating High Stakes Conversations in Gynecologic Oncology (2021 Annual Meeting session) |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward